John Griffin Invests in Teva Pharmaceutical – Nasdaq

John Griffin Invests in Teva Pharmaceutical
Nasdaq
Griffin’s stake is 0.44% of Teva Pharmaceutical’s outstanding shares and 2.92% of Griffin’s total assets. Andreas Halvorsen ( Trades , Portfolio ) is Teva Pharmaceutical’s leading shareholder among the gurus with a stake of 25,043,775 shares. The stake

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd